AC |
astrocyte cell |
ADCC |
antibody-dependent cellular cytotoxicity |
ADCP |
antibody-dependent cellular phagocytosis |
BBD |
beclin 1 binding domain |
BMP4 |
bone morphogenetic protein 4 |
CSC |
cancer stem cell |
DGC |
differentiated glioblastoma cell |
DSB |
double-strand DNA break |
E |
early |
ED50 |
median effective dose |
EGFR |
epidermal growth factor receptor |
GBM |
glioblastoma |
GEM |
genetically engineered mouse |
GSC |
glioblastoma stem-like cell |
h |
human |
HGG |
high-grade glioma |
HDAC |
histone deacetylase |
m |
mouse |
ICI |
Immune checkpoint inhibitor |
IDH |
isocitrate dehydrogenase |
IE |
immediate early |
L |
late |
MES |
mesenchymal |
MGMT |
O6-methylguanine-DNA methyltransferase |
MOI |
multiplicity of infection |
MRI |
magnetic resonance imaging |
oHSV |
oncolytic herpes simplex virus |
OPC |
oligodendrocyte progenitor cell |
OV |
oncolytic virus |
PDX |
patient-derived xenograft |
PARP |
poly(ADP-ribose) polymerase |
pfu |
plaque forming unit |
RR |
ribonucleotide reductase |
ScGC |
serum-cultured GBM cells |
TGFβ |
transforming growth factor-β |
TGFβ receptor |
TGFβ |
TIL |
tumor-infiltrating lymphocytes |
TK |
thymidine kinase |
TME |
tumor microenvironment |
TMZ |
temozolomide |
Treg |
T regulatory cell. |